Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Shilo, Konstantin ^a   Wu, Xin ^a   Sharma, Smita ^a   Welliver, Meng ^a   Duan, Wenrui ^a   Villalona Calero, Miguel ^a   Fukuoka, Junya ^b   Sif, Said ^c   Baiocchi, Robert ^a   Hitchcock, Charles L ^a   Zhao, Weiqiang ^a   Otterson, Gregory A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Lung carcinoma; Neuroendocrine tumors; Protein arginine methyltransferase 5

Indexed keywords

MESSENGER RNA; PRMT5 PROTEIN, HUMAN; PROTEIN ARGININE METHYLTRANSFERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOPLASM; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NEUROENDOCRINE TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR CELL LINE; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEUROENDOCRINE TUMORS; PROTEIN-ARGININE N-METHYLTRANSFERASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84889772752     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-201     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29. 10.3322/caac.20138, 22237781.
2. D'Angelo SP, Pietanza MC, Johnson ML, Riely GJ, Miller VA, Sima CS, Zakowski MF, Rusch VW, Ladanyi M, Kris MG. Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas. J Clin Oncol 2011, 29(15):2066-2070. 10.1200/JCO.2010.32.6181, 3296671, 21482987.
3. Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci USA 2008, 105(1):252-257. 10.1073/pnas.0710735105, 2224196, 18162535.
4. Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012, 489(7417):519-525. 10.1038/nature11404, 3466113, 22960745, Cancer Genome Atlas Research Network.
5. Vaitkiene P, Skiriute D, Skauminas K, Tamasauskas A. GATA4 and DcR1 methylation in glioblastomas. Diagn Pathol 2013, 8:7. 10.1186/1746-1596-8-7, 3599597, 23320456.
6. Guzman L, Depix MS, Salinas AM, Roldan R, Aguayo F, Silva A, Vinet R. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers. Diagn Pathol 2012, 7:87. 10.1186/1746-1596-7-87, 3424112, 22818553.
7. Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T, Sugio K, et al. DNA methylation profiles of lung tumors. Mol Cancer Ther 2001, 1(1):61-67.
8. Ji M, Zhang Y, Shi B, Hou P. Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC). Diagn Pathol 2011, 6:48. 10.1186/1746-1596-6-48, 3123260, 21639921.
9. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55(20):4525-4530.
10. Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine. Oncogene 1995, 11(6):1211-1216.
11. Wijermans P, Lubbert M, Verhoef G, Bosly A, Ravoet C, Andre M, Ferrant A. Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol 2000, 18(5):956-962.
12. Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R, Stone RM, Nelson D, Powell BL, DeCastro CM, et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 2002, 20(10):2429-2440. 10.1200/JCO.2002.04.117, 12011120.
13. Bedford MT, Richard S. Arginine methylation an emerging regulator of protein function. Mol Cell 2005, 18(3):263-272. 10.1016/j.molcel.2005.04.003, 15866169.
14. Pal S, Sif S. Interplay between chromatin remodelers and protein arginine methyltransferases. J Cell Physiol 2007, 213(2):306-315. 10.1002/jcp.21180, 17708529.
15. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004, 24(21):9630-9645. 10.1128/MCB.24.21.9630-9645.2004, 522266, 15485929.
16. Wang L, Pal S, Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol 2008, 28(20):6262-6277. 10.1128/MCB.00923-08, 2577430, 18694959.
17. Gu Z, Gao S, Zhang F, Wang Z, Ma W, Davis RE. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells. Biochem J 2012, 446(2):235-241. 10.1042/BJ20120768, 22708516.
18. Gu Z, Li Y, Lee P, Liu T, Wan C, Wang Z. Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells. PLoS One 2012, 7(8):e44033. 10.1371/journal.pone.0044033, 3428323, 22952863.
19. Karkhanis V, Wang L, Tae S, Hu YJ, Imbalzano AN, Sif S. Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase delta catalytic subunit gene, POLD1. J Biol Chem 2012, 287(35):29801-29814. 10.1074/jbc.M112.378281, 3436169, 22761421.
20. Friesen WJ, Paushkin S, Wyce A, Massenet S, Pesiridis GS, Van Duyne G, Rappsilber J, Mann M, Dreyfuss G. The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol Cell Biol 2001, 21(24):8289-8300. 10.1128/MCB.21.24.8289-8300.2001, 99994, 11713266.
21. Friesen WJ, Wyce A, Paushkin S, Abel L, Rappsilber J, Mann M, Dreyfuss G. A novel WD repeat protein component of the methylosome binds Sm proteins. J Biol Chem 2002, 277(10):8243-8247. 10.1074/jbc.M109984200, 11756452.
22. Antonysamy S, Bonday Z, Campbell RM, Doyle B, Druzina Z, Gheyi T, Han B, Jungheim LN, Qian Y, Rauch C, et al. Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci USA 2012, 109(44):17960-17965. 10.1073/pnas.1209814109, 3497828, 23071334.
23. Fukuoka J, Dracheva T, Shih JH, Hewitt SM, Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD, et al. Desmoglein 3 as a prognostic factor in lung cancer. Hum Pathol 2007, 38(2):276-283. 10.1016/j.humpath.2006.08.006, 17084439.
24. Shilo K, Dracheva T, Mani H, Fukuoka J, Sesterhenn IA, Chu WS, Shih JH, Jen J, Travis WD, Franks TJ. Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis. Arch Pathol Lab Med 2007, 131(10):1555-1560.
25. Espino PS, Drobic B, Dunn KL, Davie JR. Histone modifications as a platform for cancer therapy. J Cell Biochem 2005, 94(6):1088-1102. 10.1002/jcb.20387, 15723344.
26. Van Den Broeck A, Ozenne P, Eymin B, Gazzeri S. Lung cancer: a modified epigenome. Cell Adh Migr 2010, 4(1):107-113. 10.4161/cam.4.1.10885, 2852567, 20139698.
27. Powers MA, Fay MM, Factor RE, Welm AL, Ullman KS. Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4. Cancer Res 2011, 71(16):5579-5587. 10.1158/0008-5472.CAN-11-0458, 3156344, 21700716.
28. Cho EC, Zheng S, Munro S, Liu G, Carr SM, Moehlenbrink J, Lu YC, Stimson L, Khan O, Konietzny R, et al. Arginine methylation controls growth regulation by E2F-1. Embo J 2012, 31(7):1785-1797. 10.1038/emboj.2012.17, 3321197, 22327218.
29. Lu Q, Li N, Luo J, Yu M, Huang Y, Wu X, Wu H, Liu XY, Li G. Pinellia pedatisecta agglutinin interacts with the methylosome and induces cancer cell death. Oncogenesis 2012, 1:e29. 10.1038/oncsis.2012.30, 3503292, 23552401.
30. Gradowski JF, Mantha GS, Hunt JL, Dacic S. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs. Diagn Mol Pathol 2007, 16(2):87-90. 10.1097/PDM.0b013e318030afde, 17525677.
31. Kayser K, Kosjerina Z, Goldmann T, Kayser G, Kazmierczak B, Vollmer E. Lung carcinoma-associated atypical adenomatoid hyperplasia, squamous cell dysplasia, and chromosome alterations in non-neoplastic bronchial mucosa. Lung Cancer 2005, 47(2):205-214. 10.1016/j.lungcan.2004.07.042, 15639719.
32. Bao X, Zhao S, Liu T, Liu Y, Yang X. Overexpression PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer. J Histochem Cytochem 2013, 61(3):206-217. 10.1369/0022155413475452, 23292799.